Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Côte D'Ivoire

AIDS

Volumn 18, Issue 3, 2004, Pages 413-419

  Koblavi Dèrne, Stéphania ^a   Kestens, Luc ^b   Hanson, Debra ^c   Otten, Ronald A ^c   Borget, Marie Yolande ^a   Bilé, Célestin ^a   Wiktor, Stefan Z ^a,c   Roels, Thierry H ^a,c   Chorba, Terence ^a,c   Nkengasong, John N ^a,c  

^a Project RETRO CI Abidjan   (Côte d’Ivoire)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

CD38; HIV 2; HIV 2 RNA viral load; HIV dual infection; HLA DR

Indexed keywords

BIOCHEMICAL MARKER; CD38 ANTIGEN; HLA DR ANTIGEN; VIRUS RNA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HIV-1; HIV-2; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MALE; RNA, VIRAL; VIRAL LOAD; VIREMIA;

EID: 12144287396     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200402200-00006     Document Type: Article

References (28)

1. Clavel F, Guetard D, Brun-Vezinet F, Chamaret S, Rey MA, Santos-Ferreira MO, et al. Isolation of a new human retrovirus from West African patients with AIDS. Science 1986, 233: 343-346.
2. Kanki PJ, Barin F, M'boup S, Alan JS, Romet-Lemonne JS, Marlink R, et al. New human T - lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM). Science 1986, 232:238-243.
3. Adjorlolo-Johnson G, De Cock KM, Ekpini E, Vetter KM, Sibailly TS, Ou CY, et al. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 1994, 272:462-466.
4. Marlink RP, Kank PJ, Thior I, Travers K, Eisen G, Siby T, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science, 1994 265:1587-1590.
5. Popper SJ, Sarr AD, Travers KU, Gueye-Ndiaye A, Mboup S, Essex ME, et al. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J Infect Dis 1999, 180:1116-1121.
6. Shanmugam V, Switzer MW, Nkengasong JN, Garcia-Lerma G, Green TA, Ekpini E, et al. Lower HIV-2 plasma viral loads may explain differences between the natural histories of HIV-1 and HIV-2 infections. J Acquir Immune Defic Syndr 2000, 24: 257-263.
7. Simon F, Matheron S, Tamalet C, Loussert-Ajaka I, Batczak S, Pepin JM, et al. Cellular and plasma viral load in patients infected with HIV-2. AIDS 1993, 7:1411-1417.
8. Ishikawa K, Fransen K, Ariyoshi K, Nkengasong JN, Janssens W, Heyndrickx L, et al. Improved detection of HIV-2 proviral DNA in dually seroreactive individuals by PCR. AIDS 1998, 12: 1419-1425.
9. Sarr AD, Hamel DJ, Thior I, Kokkotou E, Sankale JL, Siby T, et al. HIV-1 and HIV-2 dual infection: Lack of HIV-2 provirus correlates with low CD4+ lymphocyte counts. AIDS 1998, 12: 131-137.
10. Nkengasong JN, Kestens L, Ghys PD, Koblavi-Deme S, Otten RA, Bile C, et al. Dual infection with human immunodeficiency virus type 1 and type 2: impact on HIV type 1 viral load and immune activation markers in HIV-seropositive female sex workers in Abidjan, Ivory Coast. AIDS Res Human Retroviruses 2000, 16:1371-1378.
11. Andersson S, Norrgren H, da Silva Z, Biague A, Bamba S, Kwok S, et al. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med 2000, 160:3286-3293.
12. Carbone J, Gil J, Benito JM, Navarro J, Munoz-Fernandez A, Bartolome J, et al. Increased levels of activated subsets of CD4 T cells add to the prognostic value of low T cell counts in a cohort of HIV-infected drug users. AIDS 2000, 14:2823-2829.
13. Nkengasong JN, Maurice C, Koblavi S, Kalou M, Yavo D, Maran M, et al. Evaluation of HIV serial and parallel serologic testing algorithms in Abidjan, Côte d'Ivoire. AIDS 1999, 13:109-117.
14. Nkengasong JN, Maurice C, Koblavi S, Kalou M, Bile C, Yavo D, et al. Field evaluation of a combination of monospecific enzyme linked immunosorbent assays for type-specific serodiagnosis of human immunodeficiency virus type 1 (HIV-1) and HIV-2 infections in HIV seropositive persons in Abidjan, Côte d'Ivoire. J Clin Microbiol 1998, 36:123-127.
15. Ellenberger DL, Pieniazek D, Nkengasong JN, Luo CC, Devare S, Maurice C, et al. Genetic analysis of human immunodeficiency virus in Abidjan, Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtypes G. AIDS Res Hum Retroviruses 1999, 15:3-9.
16. Pieniazek D, Ellenberger D, Janini LM, Ramos AC, Nkengasong JN, Sassan-Morokro M, et al. Predominance of human immunodeficiency virus type 2 subtype B in Abidjan, Ivory Coast. AIDS Res Hum Retroviruses 1999, 15:603-608.
17. Nkengasong JN, Chi-Cheng L, Abouya L, Pieniazek D, Maurice C, Sassan-Morokro M, et al. Distribution of HIV-1 subtypes among HIV-seropositive patients in the interior of Côte d'Ivoire. J Acquir Immune Defic Syndr 2000, 23:430-436.
18. Kestens L, Vanham G, Vereecken C, Vandenbruaene M, Vercauteren G, Colebunders RL, et al: Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection. Clin Exp Immunol 1994, 95:436-441.
19. Wang B, Lal RB, Dwyer DE, Miranda Saksena M, Boadle R, Cunningnam AL, et al. Molecular and biological interactions between two HIV-1 strains from a co-infected patient reveal the first evidence in favor of viral synergism. Virology 2000, 274: 105-109.
20. Sarr AD, Popper S, Thior I, Hamel DJ, Sankale JL, Siby T, et al. Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infection. J Hum Virol 1999, 2:45-51.
21. Ho DD, Neuman AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
22. Popper SJ, Sarr AD, Gueye-Ndiaye A, Mboup S, Essex ME, Kanki PJ. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo. J Virol 2000, 74:1554-1557.
23. Ariyoshi K, Jaffar S, Alabi AS, Blanchard T, Schim van der Loeff M, Awasana AA, et al. Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa. AIDS 2000, 14:339-344.
24. 2 microglobulin concentration and disease evolution. J Infect Dis 2000, 181:64-75.
25. Finzi D, and Siliciano RF. Viral dynamics in HIV-1 infection. Cell 1998, 93:665-671.
26. Damond F, Gueudin M, Pueyo S, Farfara I, Robertson DL, Descamps D, et al. Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections. J Clin Microbiol 2002, 40:3654-3659.
27. Kassim S, Sassan-Morokro M, Ackah A, Abouya LY, Digbeu H, Yesso G, et al. Two-year follow-up of persons with HIV-1 and HIV-2 associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa. AIDS 1995, 9:1185-1191.
28. Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gatell JM, et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA 2002, 288:222-235.